Assets of NYMOX PHARMACEUTICAL CORP from 31 Dec 2015 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
NYMOX PHARMACEUTICAL CORP quarterly Assets in USD history and change rate from 31 Dec 2015 to 31 Dec 2024.
  • NYMOX PHARMACEUTICAL CORP Assets for the quarter ending 31 Dec 2024 was $654,000, a 4.3% increase year-over-year.
Source SEC data
View on sec.gov
Assets, Quarterly (USD)
Assets, YoY Quarterly Change (%)

NYMOX PHARMACEUTICAL CORP Quarterly Assets (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $654,000 +$27,000 +4.3% 31 Dec 2024 20-F 03 Jun 2025 2024 FY
Q3 2024 $624,000 -$45,000 -6.7% 30 Sep 2024 6-K 02 Jan 2025 2024 Q3
Q4 2023 $627,000 -$998,000 -61% 31 Dec 2023 20-F 03 Jun 2025 2024 FY
Q3 2023 $669,000 -$2,472,000 -79% 30 Sep 2023 6-K 15 Nov 2023 2023 Q3
Q2 2023 $271,000 -$4,203,000 -94% 30 Jun 2023 6-K 14 Aug 2023 2023 Q2
Q1 2023 $575,000 -$663,000 -54% 31 Mar 2023 6-K 12 May 2023 2023 Q1
Q4 2022 $1,625,000 +$182,000 +13% 31 Dec 2022 20-F 29 Aug 2024 2023 FY
Q3 2022 $3,141,000 -$710,000 -18% 30 Sep 2022 6-K/A 16 Nov 2022 2022 Q3
Q2 2022 $4,474,000 -$2,196,000 -33% 30 Jun 2022 6-K 15 Aug 2022 2022 Q2
Q1 2022 $1,238,000 -$217,000 -15% 31 Mar 2022 6-K 13 May 2022 2022 Q1
Q4 2021 $1,443,000 -$2,900,000 -67% 31 Dec 2021 20-F 02 May 2023 2022 FY
Q3 2021 $3,851,000 -$1,889,000 -33% 30 Sep 2021 6-K 12 Nov 2021 2021 Q3
Q2 2021 $6,670,000 +$5,615,000 +532% 30 Jun 2021 6-K 13 Aug 2021 2021 Q2
Q1 2021 $1,455,000 -$1,916,000 -57% 31 Mar 2021 6-K 14 May 2021 2021 Q1
Q4 2020 $4,343,000 -$1,146,000 -21% 31 Dec 2020 20-F 30 Mar 2022 2021 FY
Q3 2020 $5,740,000 -$1,722,000 -23% 30 Sep 2020 6-K 13 Nov 2020 2020 Q3
Q2 2020 $1,055,000 -$8,460,000 -89% 30 Jun 2020 6-K 14 Aug 2020
Q1 2020 $3,371,000 -$8,429,000 -71% 31 Mar 2020 6-K 14 May 2020 2020 Q1
Q4 2019 $5,489,000 -$2,587,000 -32% 31 Dec 2019 20-F 30 Mar 2022 2021 FY
Q3 2019 $7,462,000 +$2,683,000 +56% 30 Sep 2019 6-K 13 Nov 2019 2019 Q3
Q2 2019 $9,515,000 +$4,349,000 +84% 30 Jun 2019 6-K 14 Aug 2019 2019 Q2
Q1 2019 $11,800,000 +$10,846,000 +1137% 31 Mar 2019 6-K 15 May 2019 2019 Q1
Q4 2018 $8,076,000 +$7,097,000 +725% 31 Dec 2018 20-F 29 Mar 2021 2020 FY
Q3 2018 $4,779,000 30 Sep 2018 6-K 13 Nov 2018 2018 Q3
Q2 2018 $5,166,000 30 Jun 2018 6-K 13 Aug 2018 2018 Q2
Q1 2018 $954,000 31 Mar 2018 6-K 15 May 2018 2018 Q1
Q4 2017 $979,000 -$1,078,000 -52% 31 Dec 2017 20-F 30 Mar 2020 2019 FY
Q4 2016 $2,057,000 +$1,345,000 +189% 31 Dec 2016 20-F 29 Mar 2019 2018 FY
Q4 2015 $712,000 31 Dec 2015 20-F 30 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.